| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |